188 related articles for article (PubMed ID: 16381620)
1. Conflicting methacholine challenge tests.
Haynes JM
Respir Care; 2006 Jan; 51(1):62-6. PubMed ID: 16381620
[No Abstract] [Full Text] [Related]
2. Value of the peak expiratory flow in bronchodynamic tests.
Pino JM; García-Río F; Prados C; Alvarez-Sala R; Díaz S; Villasante C; Villamor J
Allergol Immunopathol (Madr); 1996; 24(2):54-7. PubMed ID: 8933890
[TBL] [Abstract][Full Text] [Related]
3. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine.
Illamperuma C; Davis BE; Fenton ME; Cockcroft DW
Ann Allergy Asthma Immunol; 2009 May; 102(5):438-9. PubMed ID: 19496252
[No Abstract] [Full Text] [Related]
4. Variable FEV1 following methacholine inhalation.
Haynes JM
Respir Care; 2002 Aug; 47(8):915-7. PubMed ID: 12162803
[No Abstract] [Full Text] [Related]
5. Bronchodilator responsiveness following a negative methacholine challenge test.
Haynes JM
Respir Care; 2011 May; 56(5):702-6. PubMed ID: 21276323
[No Abstract] [Full Text] [Related]
6. Interpretation of the "positive" methacholine challenge.
Hewitt DJ
Am J Ind Med; 2008 Oct; 51(10):769-81. PubMed ID: 18702111
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing asthma in children: what is the role for methacholine bronchoprovocation testing?
Liem JJ; Kozyrskyj AL; Cockroft DW; Becker AB
Pediatr Pulmonol; 2008 May; 43(5):481-9. PubMed ID: 18383334
[TBL] [Abstract][Full Text] [Related]
8. Relationships of methacholine and adenosine 5'-monophosphate (AMP) responsiveness to the postbronchodilator FEV₁/FVC ratio in children with asthma.
Suh DI; Choi SH; Lee JK; Kim JT; Koh YY
J Asthma; 2011 May; 48(4):345-50. PubMed ID: 21504349
[TBL] [Abstract][Full Text] [Related]
9. The potential use of spirometry during methacholine challenge test in young children with respiratory symptoms.
Vilozni D; Livnat G; Dabbah H; Elias N; Hakim F; Bentur L
Pediatr Pulmonol; 2009 Jul; 44(7):720-7. PubMed ID: 19499592
[TBL] [Abstract][Full Text] [Related]
10. Deep inhalation bronchoprotection.
Cockcroft DW; Davis BE
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):74-5. PubMed ID: 22727163
[No Abstract] [Full Text] [Related]
11. Ipratropium bromide in the recovery phase after methacholine PD20: is there more than an antagonist effect?
Mannino F; Terzano C
Allergol Immunopathol (Madr); 1998; 26(6):273-6. PubMed ID: 9934405
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 2 methods of continuous aerosol administration during methacholine challenge testing.
Hurst TS; Cockcroft DW; Hannah VD; Davis BE
Respir Care; 2006 Jan; 51(1):46-8. PubMed ID: 16381617
[TBL] [Abstract][Full Text] [Related]
13. Same efficacies of ipratropium and salbutamol in reversing methacholine-induced bronchoconstriction.
Delpierre S; Guillot C; Badier M
J Asthma; 2006 Nov; 43(9):679-85. PubMed ID: 17092849
[TBL] [Abstract][Full Text] [Related]
14. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of three consecutive bronchoscopies after allergen challenge in volunteers with mild asthma.
Kariyawasam HH; Aizen M; Kay AB; Robinson DS
Thorax; 2007 Jun; 62(6):557-8. PubMed ID: 17536034
[No Abstract] [Full Text] [Related]
16. Bronchodilator response after negative methacholine challenge test predicts future diagnosis of asthma.
Fruchter O; Yigla M
J Asthma; 2009 Sep; 46(7):722-5. PubMed ID: 19728213
[TBL] [Abstract][Full Text] [Related]
17. Spirometry and tests of bronchial hyperresponsiveness in population studies.
Chan-Yeung M
Int J Tuberc Lung Dis; 2000 Jul; 4(7):633-8. PubMed ID: 10907766
[TBL] [Abstract][Full Text] [Related]
18. Recovery time following bronchial challenge.
Currie GP; Paterson E; Anderson WJ; Lee DK
Respir Med; 2005 May; 99(5):653. PubMed ID: 15823466
[No Abstract] [Full Text] [Related]
19. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
Crapo RO; Casaburi R; Coates AL; Enright PL; Hankinson JL; Irvin CG; MacIntyre NR; McKay RT; Wanger JS; Anderson SD; Cockcroft DW; Fish JE; Sterk PJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):309-29. PubMed ID: 10619836
[No Abstract] [Full Text] [Related]
20. The role of suggestion in asthma. II. Effects of a bronchoconstrictor drug on bronchial reactivity under bronchoconstrictor or bronchodilator suggestion.
Pastorello EA; Codecasa LR; Gerosa A; Buonocore E; Sillano V; Zanussi C
Ann Allergy; 1987 Nov; 59(5):339-40. PubMed ID: 3318573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
